Skip to main content

Peer Review reports

From: A randomized, controlled, repeat-dose study of batefenterol/fluticasone furoate compared with placebo in the treatment of COPD

Original Submission
31 May 2018 Submitted Original manuscript
7 Dec 2018 Reviewed Reviewer Report - Aykut Cilli
22 Feb 2019 Reviewed Reviewer Report - Rebecca Normansell
19 Sep 2019 Reviewed Reviewer Report - Michael Steiner
20 Nov 2019 Author responded Author comments - Courtney Crim
Resubmission - Version 2
20 Nov 2019 Submitted Manuscript version 2
17 Dec 2019 Reviewed Reviewer Report - Research Square Reviewer 1
24 Feb 2020 Author responded Author comments - Courtney Crim
Resubmission - Version 3
24 Feb 2020 Submitted Manuscript version 3
2 Mar 2020 Reviewed Reviewer Report - Research Square Reviewer 1
1 Apr 2020 Author responded Author comments - Courtney Crim
Resubmission - Version 4
1 Apr 2020 Submitted Manuscript version 4
9 Apr 2020 Author responded Author comments - Courtney Crim
Resubmission - Version 5
9 Apr 2020 Submitted Manuscript version 5
16 Apr 2020 Author responded Author comments - Courtney Crim
Resubmission - Version 6
16 Apr 2020 Submitted Manuscript version 6
Publishing
20 Apr 2020 Editorially accepted
4 May 2020 Article published 10.1186/s12890-020-1153-7

You can find further information about peer review here.

Back to article page